Prevailing hyperglycemia is critical in the regulation of glucose metabolism during exercise in poorly controlled alloxan-diabetic dogs

1 Departments of Endocrinology and Diabetes, St. Vincent's Hospital Melbourne, Fitzroy; Departments of 2 Medicine and 3 Physiology, University of Melbourne, Parkville; and 4 St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia Submitted 2 July 2004 ; accepted in final...

Full description

Saved in:
Bibliographic Details
Published in:Journal of applied physiology (1985) 2005-03, Vol.98 (3), p.930-939
Main Authors: Christopher, Michael J, Rantzau, Christian, McConell, Glenn, Kemp, Bruce E, Alford, Frank P
Format: Article
Language:English
Subjects:
Alloxan
Animals
Biological and medical sciences
Blood Glucose - metabolism
Diabetes
Diabetes Mellitus, Experimental - blood
Diabetes Mellitus, Experimental - complications
Diabetes Mellitus, Experimental - physiopathology
Diabetes. Impaired glucose tolerance
Dogs
Drug Combinations
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Exercise
Exercise Test
Fatty Acids, Nonesterified - blood
Glucose
Glucose - metabolism
Homeostasis
Hyperglycemia - blood
Hyperglycemia - complications
Hyperglycemia - physiopathology
Medical sciences
Men
Muscle, Skeletal - metabolism
Muscular system
Phlorhizin - administration & dosage
Physical Exertion
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:1 Departments of Endocrinology and Diabetes, St. Vincent's Hospital Melbourne, Fitzroy; Departments of 2 Medicine and 3 Physiology, University of Melbourne, Parkville; and 4 St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia Submitted 2 July 2004 ; accepted in final form 10 October 2004 The separate impacts of the chronic diabetic state and the prevailing hyperglycemia on plasma substrates and hormones, in vivo glucose turnover, and ex vivo skeletal muscle (SkM) during exercise were examined in the same six dogs before alloxan-induced diabetes (prealloxan) and after 4–5 wk of poorly controlled hyperglycemic diabetes (HGD) in the absence and presence of 300-min phlorizin-induced (glycosuria mediated) normoglycemia (NGD). For each treatment state, the 15-h-fasted dog underwent a primed continuous 150-min infusion of [3- 3 H]glucose, followed by a 30-min treadmill exercise test ( 65% maximal oxygen capacity), with SkM biopsies taken from the thigh (vastus lateralis) before and after exercise. In the HGD and NGD states, preexercise hepatic glucose production rose by 130 and 160%, and the metabolic clearance rate of glucose (MCRg) fell by 70 and 37%, respectively, compared with the corresponding prealloxan state, but the rates of glucose uptake into peripheral tissues (Rd tissue ) and total glycolysis (GF) were unchanged, despite an increased availability of plasma free fatty acid in the NGD state. Exercise-induced increments in hepatic glucose production, Rd tissue , and plasma-derived GF were severely blunted by 30–50% in the NGD state, but increments in MCRg remained markedly reduced by 70–75% in both diabetic states. SkM intracellular glucose concentrations were significantly elevated only in the HGD state. Although Rd tissue during exercise in the diabetic states correlated positively with preexercise plasma glucose and insulin and GF and negatively with preexercise plasma free fatty acid, stepwise regression analysis revealed that an individual's preexercise glucose and GF accounted for 88% of Rd tissue during exercise. In conclusion, the prevailing hyperglycemia in poorly controlled diabetes is critical in maintaining a sufficient supply of plasma glucose for SkM glucose uptake during exercise. During phlorizin-induced NGD, increments in both Rd tissue and GF are impaired due to a diminished fuel supply from plasma glucose and a sustained reduction in increments of MCRg. glucose uptake; plasma-derived glycolysis; skeletal muscle; f
ISSN:8750-7587
1522-1601
DOI:10.1152/japplphysiol.00687.2004